Intramuscular Triamcinolone in Severe Asthma

Publisher Website
Google Scholar
Abstract
The article by Ogirala and colleagues (Feb. 28 issue)1 concerning high-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma prompts the following comments. First, in our view the patients were probably undertreated on entry into the study: the maintenance dose of prednisone was 10 mg daily or less in half the patients (Patients 2, 6, 7, 9, 10, and 12), which is a low dose for patients at risk for fatal asthma.2 Moreover, the maintenance dose of inhaled corticosteroids (triamcinolone acetonide) is not mentioned.